Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

CRESEMBA

ISAVUCONAZONIUM SULFATE

Standard Dose
372MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CRESEMBA is listed in Drugs@FDA under application 207501 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ISAVUCONAZONIUM SULFATE Form and strength POWDER;INTRAVENOUS - 372MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-03-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview CRESEMBA is listed in Drugs@FDA under application 207501 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ISAVUCONAZONIUM SULFATE Form and strength POWDER;INTRAVENOUS - 372MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-03-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.